Pharmacoeconomics & Outcomes Research Iberia CONTACT | PORIB FOUNDATION |

Home > Project Types > CEA/CUA > Casado LF, Hernandez JA, Jarque I, Echave M, Casado MA, Castro A

Casado LF, Hernandez JA, Jarque I, Echave M, Casado MA, Castro A

/
22 Jul 2017
, ,

Casado LF, Hernandez JA, Jarque I, Echave M, Casado MA, Castro A

 

 

Cost-utility analysis of idelalisib in combination with rituximab in relapsed or refractory chronic lymphocytic leukaemia
Eur J Haematol. 2018;100:264–272

MÁS INFORMACIÓN